At a glance
ClinicalIndex Comparison RecordN/ACompleted· 86 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TREATMENT PATTERNS AND OUTCOMES IN PATIENTS TREATED WITH BENEFIX OR REFACTO/REFACTO AF - A SWEDISH COHORT STUDY
In Brief
An observational study for Hemophilia A and Hemophilia B. Completed, enrolled 86 participants.
Detailed Summary
The overall aim of the study is to describe demographic and clinical characteristics, treatment patterns and outcomes, in the populations of hemophilia patients treated with BeneFIX and ReFacto/ReFacto AF in Sweden
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophilia A, Hemophilia B
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedApr 2016
Primary CompletionDec 2017
TodayJul 2026
First PostedApr 15, 2016
Enrollment StartJan 11, 2016
Primary CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 10.2 years ago